Adipokines and psoriasis (Q37831388)

24 August 2017

1 reference

title

Adipokines and psoriasis (English)

1 reference

24 August 2017

Sascha Gerdes

1

1 reference

PubMed ID

21255085

24 August 2017

Martin Rostami-Yazdi

series ordinal

2

1 reference

PubMed ID

21255085

24 August 2017

Ulrich Mrowietz

series ordinal

3

1 reference

24 August 2017

1 February 2011

1 reference

24 August 2017

Experimental Dermatology

1 reference

24 August 2017

20

1 reference

24 August 2017

81-87

1 reference

24 August 2017

2

1 reference

Adipose tissue and adipokines: for better or worse

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipose tissue: the link between obesity and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Impact of comorbidities on the management of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Epidemiology of comorbidities in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Combined effects of HLA-Cw6, body mass index and waist-hip ratio on psoriasis vulgaris in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Managing comorbid disease in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adiponectin and inflammation: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Serum high molecular weight adiponectin levels are decreased in psoriasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Leptin and the skin: a new frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Plasma leptin and prognosis in patients with established coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Leptin promotes vascular remodeling and neointimal growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

High-dose leptin activates human leukocytes via receptor expression on monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

The role of resistin as a regulator of inflammation: Implications for various human pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipokines as emerging mediators of immune response and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Plasma resistin associated with myocardium injury in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Psoriasis: a possible risk factor for development of coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

The risk of stroke in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Type 2 diabetes and cardiovascular disease: getting to the fat of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Omentin plasma levels and gene expression are decreased in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipose tissue: the new endocrine organ? A review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Tumor necrosis factor antagonists in the therapy of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

The major inflammatory mediator interleukin-6 and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Physiological roles of muscle-derived interleukin-6 in response to exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Clinical value of blocking IL-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

IL-6 in autoimmune disease and chronic inflammatory proliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01210.X

10.1111/J.1600-0625.2010.01210.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21255085